In a BRAF-mutated melanoma mouse model, adaptive resistance alterations of CAFs leads to matrix production, remodeling and subsequent FAK activation within tumor cells to promote melanoma survival (Hirata et al., 2015). This evidence concerns the gene PTK2 and neoplasm.